National Highway Traffic Safety Administration (NHTSA), DOT.
This notice revises Model Specifications for Screening Devices to Measure Alcohol in Bodily Fluids (Model Specifications) published in the Federal Register on August 2, 1994 (59 FR 39382). These devices test for the presence of alcohol using breath or bodily fluids such as saliva. The Model Specifications support State laws that target youthful offenders (i.e., “zero tolerance” laws) and the Department of Transportation's regulations on Alcohol Misuse Prevention, and encourage industry efforts to develop new technologies (e.g., non-breath devices) that measure alcohol content from bodily fluids.
This notice removed testing of Interpretive Screening Devices (ISDs) and use of the Breath Alcohol Sample Simulator (BASS) device from the Model Specifications. The ISDs did not provide an unambiguous test result, as test results for ISDs are subjective and require interpretation by a test administrator or technician. Because the agency has determined the BASS device is not necessary for inclusion in the Model Specifications, this notice removes all references to the BASS device.
Additionally, in order to ensure product integrity, this notice provides guidelines for retesting devices when manufacturers contemplate changes, revisions, or upgrades to alcohol screening devices on the Conforming Products List (CPL).
These revisions to the Model Specifications will not affect devices currently listed on the CPL.
Effective Date: Revisions to these Model Specifications become effective on March 31, 2008.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For technical issues: Ms. De Carlo Ciccel, Behavioral Research Division, NTI-131, National Highway Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington, DC 20590; Telephone: (202) 366-1694. For legal issues: Mr. David Bonelli, Office of Chief Counsel, NCC-113, National Highway Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington, DC 20590; Telephone: (202) 366-5834.End Further Info End Preamble Start Supplemental Information
As indicated in the Model Specifications published in 1994, the agency will modify and improve the Model Specifications as new data and test procedures become available and will alter the test procedures, as necessary, to meet unique design features of specific devices. Since publication of the Model Specifications, the agency encountered difficulties ensuring the accuracy of testing ISDs and also determined the use of the BASS is not necessary for inclusion in the Model Specifications. These events made it necessary to revise the Model Specifications.
On December 14, 2007, (72 FR 71188), NHTSA proposed and sought comments on amendments and revisions to the Model Specifications published in 1994. In the notice, NHTSA explained that the 1994 Model Specifications allowed for evaluation of screening devices that require subjective interpretation of test results by a test administrator or technician. These ISDs differ from devices that provide objective test results, including the use of digital technology or the appearance of lights or marks based on the presence or absence of alcohol. For instance, use of pass/fail lights or enzymes that react with alcohol to produce an unambiguous mark provide objective test results. Also, the 1994 Model Specifications required that interpretive devices be evaluated subjectively under five lighting conditions (fluorescent, incandescent, mercury, sodium and daylight) by a panel of ten novice evaluators who are not color blind. Since publication of the 1994 Model Specifications, NHTSA evaluated eight separate ISDs. Of those eight ISD evaluations, none resulted in a successful outcome in the panel test described above. In one evaluation, the device passed the test under all lighting conditions except sodium. This device is no longer manufactured. Although many novice evaluators were able to judge the correct test outcome in the eight ISD evaluations, some could not, even though the manufacturers' instructions were conveyed to the evaluators and all evaluators passed tests to determine their color perception ability. This subjective interpretation of test results does not ensure accuracy and precision required to protect public safety. Due to repeated problems in evaluating ISDs, NHTSA proposed to remove altogether testing of ISDs and all references to interpretive or color indicator tests from the Model Specifications.
The 1994 Model Specifications provided for the use of the Breath Alcohol Sample Simulator (BASS) device for delivering alcohol-in-air test samples. The use of the BASS device is not necessary for inclusion in the Model Specifications because the BASS device is intended for use in testing the sampling efficiency of evidential breath testers. There is no sampling efficiency test in the Model Specifications for alcohol screening devices. The alcohol-in-air test sample for breath alcohol screening devices is supplied by a calibrating unit. Therefore, the agency proposed to remove all references to the BASS device from the Model Specifications.
The 1994 Model Specifications also provide procedures to conduct special investigations and re-test a device if information gathered indicates that a device listed on the CPL is not performing in accordance with the Model Specifications. The agency proposed the addition of Appendix B to provide guidance regarding notification and re-testing when manufacturers contemplate revisions to devices listed on the CPL. The proposed Appendix follows the language used in the Model Specifications for evidential breath testing devices (58 FR 48705). Upon notification by a manufacturer of a contemplated change to a device listed Start Printed Page 16957on the CPL, NHTSA proposed that it would determine whether re-testing is required. Such determination would look at several factors, including the nature and reason for the change, the scope of the change, the effects of the change on the performance of the device, and how the change will be documented for the benefit of the user. NHTSA would list device revisions and whether re-testing was required in the next update to the CPL. Appendix B also would state that NHTSA may re-test any device listed on the CPL at any time to determine continued compliance and performance with the Model Specifications. A device found not to perform in accordance with the Model Specifications would be subject to the special investigation procedures discussed below.
Having received no comments on any aspect of the agency's proposal, this notice adopts the proposed revisions, including the “Procedures” and “Model Specifications for Alcohol Screening Devices,” without change.
This section describes the current procedures. The DOT Volpe National Transportation Systems Center (VNTSC), RTV-4F, Kendall Square, Cambridge, MA 02142 tests products manufacturers submit to determine whether the products meet the model specifications. Tests are conducted semiannually, or as necessary. Manufacturers are required to apply to NHTSA for a test date by writing to the Office of Behavioral Safety Research, NTI-130, NHTSA, 1200 New Jersey Avenue, SE., Washington, DC 20590. At least 30 days are typically required from the date of notification until the test can be scheduled.
One week prior to the scheduled initiation of the test program, manufacturers must deliver their devices to VNTSC. If the devices are disposable, the manufacturer must deliver at least 300 such devices; if the devices are reusable, the manufacturer need submit only a single device. If a manufacturer of a reusable device wishes to submit a duplicate, backup instrument, it may so do. The manufacturer is responsible for ensuring that the devices operate properly and are packaged correctly. The manufacturer must also deliver the operator's manual (or instructions) and the maintenance manual (if any) that is to be supplied with the purchase of the device, as well as specifications and drawings fully describing the device and its use. Information determined to be proprietary will be respected. (See 49 CFR Part 512, regarding the procedure by which NHTSA will consider claims of confidentiality.)
In addition, the manufacturer must submit a self-certification, certifying that the manufacturer meets the requirements according to the U.S. Food and Drug Administration (FDA) Good Manufacturing Practices regulations for devices used for medical purposes (21 CFR Part 820), and that the device's label meets the requirements in FDA's Labeling regulations for devices used for medical purposes (21 CFR Part 809.10), even if the devices are not to be used for medical purposes. See Appendix A to this notice.
The manufacturer has the right to check its device(s) between the time of arrival at VNTSC and the start of the tests, but will have no access to the device(s) during the tests. Any malfunction of a device resulting in failure to complete any of the tests satisfactorily will result in a determination that the device does not conform to the Model Specifications. If a device is found not to conform to the Model Specifications, it may be resubmitted for the next testing cycle after appropriate corrections have been made. However, the agency reserves the discretion to determine whether to conduct any retest.
The agency intends to update and republish the CPL in the Federal Register annually. Republications of the CPL add conforming alcohol screening devices tested since the last CPL republication.
NHTSA will continue to provide notification in the Federal Register when the agency amends the Model Specifications as new data and test procedures become available and will retest devices when necessary.
The NHTSA Office of Behavioral Safety Research is the point of contact for information about acceptance testing and field performance of devices that are in the marketplace. NHTSA requests that users of alcohol screening devices provide both acceptance and field performance data to the Office of Behavioral Safety Research when such data indicate potential performance problems. Information from users will help NHTSA monitor whether alcohol screening devices are performing according to the NHTSA Model Specifications.
If information gathered indicates that a device on the CPL is not performing in accordance with the Model Specifications, NHTSA may direct VNTSC to conduct a special investigation. An investigation may include visits to users and additional tests of devices obtained on the open market. If the investigation indicates that a device actually sold on the market does not meet the Model Specifications, the manufacturer will be notified that the device may be removed from the CPL. In this event, the manufacturer will have 30 days from the date of notification to reply. Based on the VNTSC investigation and any data provided by the manufacturer, NHTSA will decide whether the device should remain on the CPL. If the device is removed from the CPL, the manufacturer will be permitted to resubmit an improved device to VNTSC for testing when it believes the problems causing its failure have been resolved. Upon resubmission, the manufacturer must submit a statement describing what has been done to overcome the problems that led to failure of the device. The agency reserves the discretion to determine whether to conduct any retest.
If information gathered indicates that the manufacturer of a device on the CPL does not comply with the requirements in FDA's Good Manufacturing Practices regulations for devices used for medical purposes or that the device's label does not comply with the requirements in FDA's labeling regulations for devices used for medical purposes, NHTSA may investigate the matter in consultation with FDA and will notify the manufacturer that the device may be removed from the CPL. The manufacturer will have 30 days from the date of notification to reply. Based on any data provided by the manufacturer and investigative findings, NHTSA will decide whether the device should remain on the CPL. If the device is removed from the CPL, the manufacturer will be permitted to resubmit a self-certification, certifying that the manufacturer or its device complies with these FDA requirements when it believes the problems causing its non-compliance have been resolved. Upon resubmission, the manufacturer must submit a statement describing what has been done to overcome the problems that led to non-compliance.
In accordance with the foregoing, the amendments of the Model Specifications for Screening Devices to Measure Alcohol in Bodily Fluids, are set forth below.
Model Specifications for Alcohol Screening Devices
1. Purpose and Scope
These specifications establish performance criteria and methods for testing of alcohol screening devices. Alcohol screening devices use bodily fluids to detect the presence of 0.020 or more BAC (see below) with sufficient Start Printed Page 16958accuracy for screening purposes. These specifications are intended primarily for use in the conformance testing of alcohol screening devices.
2.1 Disposable Alcohol Screening Devices.
Alcohol screening devices designed for a single use.
2.2 Reusable Alcohol Screening Devices.
Alcohol screening devices designed to be reused.
The intoxicating agent in beverage alcohol, ethyl alcohol or other low molecular weight alcohols including methyl or isopropyl alcohol.
3.2 Alcohol Screening Device.
A device that is used to detect the presence of 0.020 or more BAC. The device may measure any bodily fluid for this purpose, but shall provide output in BAC units. Test results must be indicated unambiguously by numerical read-out or by other means, such as by the use of lights or by the appearance of a distinctive mark but not by color change.
3.3 Blood alcohol concentration (BAC).
Grams alcohol per 100 milliliters of blood or grams alcohol per 210 liters of breath in accordance with the Uniform Vehicle Code, Section 11-903(a)(5)  (BrAC is often used to indicate that the measurement is a breath measurement); or grams alcohol per 100 milliliters of saliva.
3.4 Calibrating Unit.
A device that produces an alcohol-in-air test sample of known concentration and that meets the NHTSA Model Specifications for Calibrating Units (72 FR 34742).
3.5 Bodily Fluid.
Any bodily fluid capable of being used to estimate alcohol concentration, provided the relationship between such bodily fluid and BAC has been established according to scientifically acceptable standards. Such fluids include but are not limited to blood, exhaled deep lung breath and saliva.
3.6 Scientifically Acceptable Substitutes.
Fluids that have been scientifically accepted as equivalent to bodily fluids for testing purposes, such as aqueous alcohol test solutions on a one-to-one basis for blood or saliva.
4. Test Methods and Requirements
Testing will be performed according to the instructions that normally accompany the submitted device and under the conditions specified in the tests below.
4.1 Test 1. Precision and Accuracy.
Perform 40 trials under normal laboratory conditions including 20 trials at 0.008 BAC and 20 trials at 0.032 BAC. Use a calibrating unit for this test for breath devices and preparations of bodily fluids or scientifically acceptable substitutes for non-breath devices. Perform tests using a VNTSC investigator.
To conform at 0.008 BAC, not more than one positive result. To conform at 0.032 BAC, not more than one non-positive result.
4.2 Test 2. Blank Reading.
Perform 20 trials under normal laboratory conditions at 0.000 BAC. Use non-alcoholic human breath for breath devices and non-alcoholic bodily fluids or scientifically acceptable substitutes for non-breath devices. Perform tests using a VNTSC investigator.
To conform: no positive results. If the device is capable of providing a reading of greater than 0.000 BAC and less than 0.020 BAC, not more than one such result.
4.3 Test 3. Cigarette smoke interference (only breath and saliva test devices).
Perform five trials at 0.000 BAC. Select an alcohol-free person who smokes cigarettes for this test. Ask the person selected to smoke approximately one half of a cigarette. Within one minute after smoking, or after a waiting period specified in the manufacturer's instructions, administer the alcohol screening device test according to the manufacturer's instructions. Then ask the person to take another smoke and repeat the test to produce a total of five trials.
To conform: no positive results.
Test at low and high ambient temperature.
4.4.1 Test 4.1. Low Ambient Temperature.
Perform 40 trials at 10 degrees Centigrade (C), including 20 trials at 0.008 BAC and 20 trials at 0.032 BAC. Use a calibrating unit for this test for breath devices and preparations of bodily fluids or scientifically acceptable substitutes for non-breath devices.
To conform at 0.008 BAC, not more than one positive result. To conform at 0.032 BAC, not more than one non-positive result.
4.4.2 Test 4.2 High Ambient Temperature.
Perform trials of 40 devices at 40 degrees C, including 20 trials at 0.008 BAC and 20 trials at 0.032 BAC. Use a calibrating unit for this test for breath devices and preparations of bodily fluids or scientifically acceptable substitutes for non-breath devices.
To conform at 0.008 BAC, not more than one positive result. To conform at 0.032 BAC, not more than one non-positive result.
4.5. Test 5. Vibration.
Perform 40 trials, including 20 trials at 0.008 BAC and 20 trials at 0.032 BAC. Use a calibrating unit for this test for breath devices and preparations of bodily fluids or scientifically acceptable substitutes for non-breath devices.
Mount the screening device on a shake table and vibrate the table in simple harmonic motion through each of its three major axes, as specified below. Sweep through each frequency range in 2.5 minutes, then reverse the sweep to the starting frequency in 2.5 minutes. Disposable testers may be placed in a suitable box mounted on the shake table. Test after vibration.
|Frequency (hertz)||Amplitude (inches, peak to peak)|
|10 to 30||0.30|
|30 to 60||0.15|
To conform at 0.008 BAC, not more than one positive result. To conform at 0.032 BAC not more than one non-positive result.
Appendix A—Labeling Instructions for Alcohol Screening Devices' Intended Use Provide the intended use including the specimen matrix (e.g. saliva, breath), the assay type (quantitative, semi-quantitative), the purpose of performing the assay, and the individual designated to perform the assay.
e.g.: This product is intended for the (quantitative, semi-quantitative) determination of alcohol in —define matrix (for e.g., saliva, breath, sweat) to perform screening alcohol assays.
This product is recommended for use by individuals who have been trained in the administration of screening devices.
Description of Testing System
Provide the principles of the procedure for performing the alcohol screening assay.
e.g.: This product uses (alcohol dehydrogenase, infrared technology, etc.) to perform the test.
Chemical Reaction Sequence
Describe the chemical reaction sequence, if applicable. Start Printed Page 16959
Reagents: List the concentration, strength, and composition of the reactive ingredients.
List the non-reactive ingredients.
Reagent Preparation and Storage
Provide instructions for preparing the reagents, if applicable.
Provide instructions for storing the reagents, if applicable.
Provide any signs of deterioration of the reagents, if applicable.
Provide the reagents' shelf life and opened expiration dating, if applicable.
e.g.: Tests in unopened packaging are stable until the date printed on the product container when stored at 22-28 degrees C. If packaging is opened, tests must be conducted at once.
Provide a caution not to use the reagents beyond the expiration date.
1. List any reagents that may be hazardous such as caustic compounds, sodium azide or other hazardous reagents and instructions for disposal, if applicable.
2. Provide warning to user to treat all samples as potentially infective. Include instructions for handling and disposal of the sample.
Provide instructions for collecting and handling the sample.
Provide criteria for specimen rejection, if applicable.
Disposable tests are pre-calibrated. No additional calibration is required.
Reusable (Instrumented) tests require calibration.
Provide information regarding how calibrations are to be conducted, if applicable, including the number and concentration of calibrators, and the frequency of calibration.
Provide instructions for calibration and recalibration.
Provide the criteria for acceptability of calibration.
Test Procedure (Disposable)
Provide adequate step-by-step instructions for performing the test and determining the results.
Test Procedure (Re-usable/Instrumented)
Provide adequate step-by-step instruction for performing the test.
Provide the installation procedures and, if applicable, any special requirements.
Provide the space and ventilation requirements.
Provide the description of the required frequency of equipment maintenance and function checks.
Provide the instructions for any remedial action to be taken when the equipment performs outside of its operating range.
Provide any operational precautions and limitations.
Provide instructions for the protection of equipment and instrumentation from fluctuations or interruptions in electrical current that could adversely affect test results and reports, if applicable.
Quality Control (QC)
If applicable, the function and stability of the test can be determined by the examination of the procedural “built in” controls contained in the product. If these controls are not working, the test is invalid and must be repeated.
If external quality control materials are used, provide the number, type, matrix and concentration of the QC materials.
Provide directions for performing quality control procedures.
Provide an adequate description of the remedial action to be taken when the QC results fail to meet the criteria for acceptability.
Provide directions for interpretation of the results of quality control samples.
Describe how the user obtains the test results, e.g., from an instrument read-out, printout, etc.
Describe the results in terms of blood alcohol concentration.
Describe what concentration indicates a positive result and what concentration indicates a negative result.
List the substances or factors that may interfere with the test and cause false results including technical or procedural errors.
Provide the operating range of the product.
Precision and Accuracy
Only devices that meet the precision and accuracy of these Model Specifications will be included on NHTSA's Conforming Products List for alcohol screening devices.
List the substances that have been evaluated with your product that do or do not interfere at the concentration indicated.
Provide pertinent bibliography.
List an 800 number the user may contact for further information or technical assistance.
Appendix B—Guidelines for Re-testing of Modified Screening Devices
Manufacturers contemplating revisions to an alcohol screening device listed on the Conforming Products List (CPL) are advised that the revision may affect the status of the device on the CPL. The manufacturer should inform NHTSA of the contemplated change so that a judgment can be made whether or not re-testing the revised alcohol screening device is necessary. The following lists the type of information NHTSA uses in determining the necessity to re-test an alcohol screening device, and is provided as guidance to manufacturers:
- Manufacturer and Model Name.
- Nature and reason for change(s).
- Scope of change(s) (e.g., Will existing devices be retrofitted? Will the change apply to some users but not others?)
- Will the change(s) affect performance of the device with regard to the Model Specifications? (Precision and accuracy, blank reading, temperature operations, or vibrations.)
- How will the change(s) be documented for the benefit of the user? (e.g., Will the change(s) be documented in service bulletins and/or service manuals? If not, why not?)
If necessary for clarity, drawings of the listed and changed device may also be helpful in NHTSA's deliberations.
If, upon review of information provided by a manufacturer, it is determined that re-testing is not warranted, a statement to that effect will be included in the next scheduled CPL update.
NHTSA reserves the right to test any CPL-listed device on the open market to determine continued compliance and performance in accordance with these Model Specifications. Devices found not to comply with or perform in accordance with the Model Specifications are subject to the investigation provisions stated above in section II, Procedures.Start Signature
Issued on: March 25, 2008.
Associate Administrator for the Office of Research and Program Development.
[FR Doc. E8-6520 Filed 3-28-08; 8:45 am]
BILLING CODE 4910-59-P